Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial O-antigen is a highly variable, repetitive polysaccharide chain extending from the lipopolysaccharide (LPS) molecule on the surface of Gram-negative bacteria. It serves as a major antigenic determinant and is targeted by the host immune system. Its variability between strains allows for serotyping and contributes to immune evasion, making it a key factor in bacterial pathogenesis and vaccine development.
Opsonization, complement activation, neutralization
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial O-antigen (O-antigen).